You are here: Industry Insights > combo

News List

Combo Antithrombotic Therapy Increases Bleeding Risk drugs
September 18, 2019
Patients with chronic coronary artery disease or peripheral artery disease treated with the combination of rivaroxaban and aspirin face a greater risk for bleeding versus patients treated with aspirin alone...
Underused Drug Combo May Up Survival in Lung Transplant drugs
September 06, 2019
A little used immunosuppression regimen may substantially improve survival following lung transplant, according to a study published online in JAMA Network Open.
Roche's Tecentriq+chemo combo shows first-line benefit in small cell lung cancer pharmafile
September 27, 2018
Roche has unveiled new Phase 3 data for its cancer immunotherapy Tecentriq (atezolizumab) in combination with carboplatin and etoposide chemotherapy as a first-line treatment...
AbbVie dumps Galapagos’ cystic fibrosis combo on back of underwhelming data drop fiercebiotech
July 09, 2018
AbbVie has dumped one of Galapagos’ cystic fibrosis regimens after getting a look at underwhelming clinical data on a component of the triple combination.
Ready to challenge Novartis and Roche, Array scores FDA nod for melanoma combo fiercepharma
June 29, 2018
Twenty years after it began, Array BioPharma has its first two drug approvals, a cancer drug combo that'll transform care for certain melanoma patients, the company's CEO says. But they'll face a couple of heavyweight pharmas in the field.
Anika’s combo arthritis drug Cingal flunks phase 3 test fiercebiotech
June 25, 2018
It’s turned out to be a challenging 2018 for Anika Therapeutics’ new CEO Joseph Darling—and a failed phase 3 trial for lead pipeline drug Cingal won’t make his job any easier.
Kitov's combo gets FDA approval in osteoarthritis and hypertension pharmafile
June 07, 2018
Israeli biopharmaceutical firm is celebrating the approval in the US of Consensi, a combo of the calcium channel blocker amlodipine and the nonsteroidal anti-inflammatory drug (NSAID) celecoxib, after the FDA authorised the drug for the treatment of osteo